A panel of human purified protein derivative of the tubercle bacillus (PPD)-reactive T cell clones was derived by cloning out of soft agar followed by cultivation on inactivated feeder cells in the presence of interleukin-2.
Introduction
Human peripheral blood monocytes have been shown to increase surface expression of a procoagulant activity (PCA)' upon stimulation with a variety of agents (1) . Most described stimuli, such as bacterial lipopolysaccharide (LPS), are polyclonal activators. No specific recognition of the stimulus by a distinct reactive cellular subset is required for the reaction to take place. Cells of the immune system can also respond to a specific sensitizing protein antigen by increasing surface expression of PCA (2, 3). 1 . Abbreviations used in this paper: FCS, fetal calf serum; LPS, lipopolysaccharide; PBM, peripheral blood mononuclear cells; PCA, procoagulant activity; PPD, purified protein derivative of the tubercle bacillus; [3H]TdR, tritiated thymidine.
This reactivity demonstrates specificity, as protein antigen to which an individual is not sensitized will not cause that individual's peripheral blood mononuclear cells (PBM) to express increased amounts of PCA (2, 4) . The cellular interactions required for expression of PCA in response to polyclonal activators, and a specific sensitizing antigen, or alloantigen, appear to be quite different (4) (5) (6) (7) . The LPS-driven response requires the stimulus to interact with T cells, which then instruct monocytes to synthesize and express increased amounts of PCA. The response reaches maximum amplitude in as short as 6 h (5). The response to specific, complex antigen, however, requires that the antigen first be processed by the monocyte/macrophage (8) . As might be predicted from analyses of other immune functions, the antigen-presenting cell presents antigen to immune lymphocytes which can then instruct a second population of monocytes to express high levels of PCA (4) . These interactions require between 24 and 48 h to develop maximum amounts of PCA, and the interactions can be blocked by a monoclonal antibody that binds the HLA-DR antigen (4). These findings are highly suggestive ofa role for monocyte PCA in the controlled, specific immune response. To further investigate this and allow studies of interactions between well-defined cell populations, we examined a series ofpurified protein derivative of tubercle bacillus (PPD)-reactive human T cell clones for their ability to cooperate with monocytes in the production of monocyte PCA.
Methods
Cell and incubations. Antigens were PPD (National Institute of Allergy and Infectious Diseases, Bethesda, MD) and Candida Albicans yeast phase disrupted at 10,000 psi. A panel of PPD-specific T cell clones derived from peripheral blood lymphocytes of an individual who demonstrated a positive skin test to this antigen were prepared by soft agar cloning as previously described (9, 10) . These cells were selected for specific proliferative responses to PPD, maintained on irradiated autologous feeder PBM, and grown in the presence of T cell growth factor (9, 10) . Clones were maintained in vitro for up to 3 mo before use in these experiments. Commercially available monoclonal antibody reagents to human lymphocyte surface markers and fluorescence-activated flow cytometry (1 1 Ag/ml streptomycin, and 15% heat inactivated (560C, 30 min) pooled human serum. PCA was determined in a parallel set ofcultures no sooner than 10 d after the addition of irradiated feeder cells, at which time no feeder cells remained. Cells of individual T cell clones were combined with autologous monocytes that had been isolated by incubating 5 X 106 PBM/ml RPMI-1640 plus 10% human serum in 35-mm gelatincoated plates (12) . The cells were incubated for 2 h at 370C, 5% Co2, nonadherent cells washed off, and monocytes were removed by incubating at 40C in Puck's Saline A (Gibco Laboratories) without Ca", supplemented with 25 mM Hepes buffer and I mM EDTA. After further washing in RPMI-1640, the monocytes (95-98% nonspecific esterase positive [13] ) were used as indicated. For elaboration of PCA, PBM (I X 106), cloned T cells (5 X IO'), monocytes (I X IO'), or indicated combinations were incubated 48 h at 370C, 5% CO2 in I ml RPMI-1640 supplemented as above with the exclusion of human serum; 10% heat inactivated fetal calf serum (FCS) (Sterile Systems, Logan, UT) was used instead. The cells were then washed with, and resuspended in 0.5 ml serum-free RPMI-1640 for PCA assay. Viability of monocytes was always >89% at time of assay.
PCA assay (5, 6) . Cell suspension (0.1 ml) and pooled human, plateletpoor plasma (anticoagulated with final concentration of 0.38% sodium citrate) (0.1 ml) were combined at 370C. CaCI2 (0.1 ml of 25 mM) was added and time-to-clot formation measured by fibrometer. Clotting time in seconds was transformed to milliunits PCA by reference to a standard curve. Undiluted rabbit brain thromboplastin (American Dade, Miami, FL) reconstituted as per manufacturer's recommendations was assigned an activity of 100,000 mU. Tenfold dilutions of this thromboplastin were assayed for clotting time to generate a standard curve for coagulant activity that was linear from I to 10,000 mU. Clotting assays on dilutions of PCA-positive monocytes generated a curve parallel to that obtained with rabbit brain thromboplastin. PCA (Table I) . Monocytes alone, with no added lymphocytes, showed a slight increase in PCA upon the addition of antigen. In all probability, this was due to the few (2-5% by nonspecific esterase staining) lymphocytes that remained in the adherent cell population. Cells from the T cell clones alone consistently demonstrated no detectable PCA. PBM that were irradiated and kept in culture for 1 wk, as were the irradiated feeder cells, likewise showed no ability to increase monocyte PCA upon addition of antigen.
We next sought to demonstrate antigen specificity of the procoagulant response as has been shown for whole peripheral blood mononuclear cells (2) (3) (4) . The individual from whom the The demonstration that monocyte PCA can be induced by a single T cell-derived clone in response to the specific sensitizing antigen speaks for a role of monocyte PCA in the immune response. These cellular reagents will make it possible to accurately describe the cellular events and interactions that are necessary in this particular effector mechanism of the immune response.
